Skip to content
  • About Us
  • Our Businesses
    • Finsource Credit
    • Ecolite
    • Eye Nation
    • YanMing
  • Investor Relations
    • IR Home
    • Corporate Governance
    • Corporate Structure
  • Policies
    • Anti-Corruption
    • Environmental
  • News & Events
    • Internal Activities
    • Business Events
    • Newsletters Update
Menu
  • About Us
  • Our Businesses
    • Finsource Credit
    • Ecolite
    • Eye Nation
    • YanMing
  • Investor Relations
    • IR Home
    • Corporate Governance
    • Corporate Structure
  • Policies
    • Anti-Corruption
    • Environmental
  • News & Events
    • Internal Activities
    • Business Events
    • Newsletters Update
Explore With Us And Keep Up To Date

宏诚集团业绩回稳,九个月税前盈利达568万令吉

Sunzen posts RM1.94mil net profit on RM27.35mil revenue in Q2

Sunzen sells two animal health subsidiaries for RM17.3 mil

Sunzen Group Shareholders Approve All Resolutions

Sunzen Biotech expands its reach into the ophthalmic industry by acquiring a stake in Eye Nation Medical

Sunzen Biotech is eyeing a larger share of China’s bird’s nest market

« Previous Page1 Page2 Page3 Page4 Page5 Next »

CONTACT US

Useful Links

  • About Us
  • Our Companies
  • Investor Relations
  • Business Events
  • Privacy Notice
  • About Us
  • Our Companies
  • Investor Relations
  • Business Events
  • Privacy Notice

Our Company

  • Product
  • Contact
  • Privacy
  • Product
  • Contact
  • Privacy

Contact Info

No. 13, Jalan Anggerik Mokara 31/47, Kota Kemuning, 40460 Shah Alam, Selangor, MALAYSIA

+603 5122 9333

info@sunzengroup.com

Copyright © 2022 Sunzen Group Berhad (formerly known as Sunzen Biotech Berhad) (200501003843 (680889-W)). All rights reserved.